Northway Biotech Capacity Update October 2025: Large Molecule

Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced and professional team executes projects at every stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise and vertically integrated service offering enables rapid execution of multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development, and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and operates locations in Vilnius, Lithuania; London, United Kingdom; and Waltham, MA, USA.

André Markmann, VP of Business Development, highlights Northway Biotech’s rise as a global biologics CDMO - built on 20+ years of expertise, 185+ successful projects, and end-to-end microbial and mammalian facilities in Waltham, Massachusetts, and Vilnius, Lithuania.